SCHEMBL10313626

SCHEMBL10313626

Cc1ccc(-n2c(C)nc3c(=N)n(/N=C\c4ccc(C#N)cc4)cnc32)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 1/20 0.37
KMT2A Q03164 3/20 0.34
RAB9A P51151 2/20 0.34
ALDH1A1 P00352 6/20 0.34
LMNA P02545 3/20 0.33
GAA P10253 3/20 0.33
NPSR1 Q6W5P4 2/20 0.33
HTT P42858 2/20 0.33
PI4KA P42356 1/20 0.32
PI4K2B Q8TCG2 1/20 0.32
PI4K2A Q9BTU6 1/20 0.32
PI4KB Q9UBF8 1/20 0.32
CYP2A6 P11509 1/20 0.32
MAPT P10636 3/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
POLB P06746 1/20 0.32
CYP19A1 P11511 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10275564 0.91 MEN1 (0.42) CRHR1KMT2ARAB9AALDH1A1GAA
SCHEMBL10275684 0.91 CRHR1 (0.35) CRHR1KMT2ARAB9AALDH1A1PI4KA
SCHEMBL10275922 0.91 CRHR1 (0.35) CRHR1KMT2ARAB9AALDH1A1PI4KA
SCHEMBL10313627 0.85 GRM5 (0.36) KMT2ARAB9AGAAHTTPI4KA
SCHEMBL10313617 0.84 RAB9A (0.36) KMT2ARAB9AALDH1A1LMNAGAA
SCHEMBL10275526 0.81 PIK3CA (0.41) CRHR1KMT2AALDH1A1LMNAHTT
SCHEMBL10275291 0.79 ADORA2A (0.39)
SCHEMBL10275364 0.73 RAB9A (0.33) KMT2ARAB9AALDH1A1LMNAGAA
SCHEMBL10276158 0.73 KIF11 (0.36) KMT2ARAB9AALDH1A1GAANPSR1
SCHEMBL10276444 0.73 KIF11 (0.36) KMT2ARAB9AALDH1A1GAANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF TYMP, TYMS, ADORA3 CRHR1 1464/4885KMT2A 4649/4885RAB9A 3784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.